ViewRay (VRAYQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock VRAYQ vs. GMVDF, SDCCQ, AHPI, NMRD, VIVE, UTRS, MOTS, DRTSW, ANZUW, and IONMShould you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include G Medical Innovations (GMVDF), SmileDirectClub (SDCCQ), Allied Healthcare Products (AHPI), Nemaura Medical (NMRD), Viveve Medical (VIVE), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), and Assure (IONM). These companies are all part of the "medical equipment" industry. ViewRay vs. G Medical Innovations SmileDirectClub Allied Healthcare Products Nemaura Medical Viveve Medical Minerva Surgical Motus GI Alpha Tau Medical Anzu Special Acquisition Corp I Assure ViewRay (NASDAQ:VRAYQ) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, community ranking, dividends, risk and profitability. Which has more risk & volatility, VRAYQ or GMVDF? ViewRay has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500. Comparatively, G Medical Innovations has a beta of 57.95, meaning that its stock price is 5,695% more volatile than the S&P 500. Does the media prefer VRAYQ or GMVDF? In the previous week, G Medical Innovations had 1 more articles in the media than ViewRay. MarketBeat recorded 1 mentions for G Medical Innovations and 0 mentions for ViewRay. ViewRay's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score. Company Overall Sentiment ViewRay Neutral G Medical Innovations Neutral Does the MarketBeat Community favor VRAYQ or GMVDF? ViewRay and G Medical Innovations both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformViewRayN/AN/AG Medical InnovationsN/AN/A Do institutionals and insiders believe in VRAYQ or GMVDF? 15.5% of ViewRay shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 2.5% of ViewRay shares are owned by company insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has stronger earnings and valuation, VRAYQ or GMVDF? G Medical Innovations has lower revenue, but higher earnings than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViewRay$102.21M0.00-$107.33MN/AN/AG Medical Innovations$4.42M0.01-$24.63MN/AN/A Is VRAYQ or GMVDF more profitable? Company Net Margins Return on Equity Return on Assets ViewRayN/A N/A N/A G Medical Innovations N/A N/A N/A SummaryG Medical Innovations beats ViewRay on 4 of the 6 factors compared between the two stocks. Get ViewRay News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart VRAYQ vs. The Competition Export to ExcelMetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$18,000.00$3.11B$5.32B$7.35BDividend YieldN/A1.82%5.47%4.34%P/E RatioN/A14.8721.9417.82Price / SalesN/A43.57380.9597.73Price / CashN/A44.0938.3134.64Price / BookN/A3.336.453.98Net Income-$107.33M$94.03M$3.22B$247.81M ViewRay Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRAYQViewRayN/AN/AN/AN/A$18,000.00$102.21M0.00300Gap UpGMVDFG Medical InnovationsN/A$0.00flatN/AN/A$52,000.00$4.42M0.0072News CoverageSDCCQSmileDirectClubN/A$0.00flatN/AN/A$40,000.00$470.74M0.002,700AHPIAllied Healthcare ProductsN/AN/AN/AN/A$16,000.00$27.05M0.00150Analyst ForecastNews CoverageGap UpNMRDNemaura MedicalN/A$0.00flatN/A-99.8%$8,000.00$3,017.000.0040VIVEViveve MedicalN/A$0.00flatN/A+0.0%$2,000.00$6.83M0.0070UTRSMinerva SurgicalN/AN/AN/AN/A$1,000.00$51.69M0.00160MOTSMotus GIN/A$0.00flatN/A-99.9%$1,000.00$319,000.000.0030DRTSWAlpha Tau MedicalN/A$0.21+3.2%N/AN/A$0.00N/A0.0080Positive NewsANZUWAnzu Special Acquisition Corp IN/A$0.03flatN/AN/A$0.00N/A0.002IONMAssureN/AN/AN/AN/A$0.00$149,000.000.00130Upcoming Earnings Related Companies and Tools Related Companies G Medical Innovations Alternatives SmileDirectClub Alternatives Allied Healthcare Products Alternatives Nemaura Medical Alternatives Viveve Medical Alternatives Minerva Surgical Alternatives Motus GI Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Assure Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRAYQ) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViewRay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRAYQ Stock Free VRAYQ Stock Alerts